Michael Dubé

Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons

National Institute on Aging · R01

PI · $1.4M · University of California, San Diego

Microbial Translocation and HIV-Related Endothelial Dysfunction

National Institute of Allergy and Infectious Diseases · R21

Contact PI · $243K · University of Southern California

General Clinical Research Center

National Center for Research Resources · M01

Project lead · $1.5M · Indiana University Indianapolis

Endothelial Dysfunction Due to HIV-1 Protease Inhibitors

National Heart, Lung, and Blood Institute · R01

Contact PI · $2M · Indiana University Indianapolis

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

Principal investigator · Completed

Indiana University

Sitagliptin for Reducing Inflammation and Immune Activation

Study chair · Completed · Phase 2

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate

Study chair · Completed · Phase 2

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections